Search

everythinglearnresearchcommunity

for

Search:↓

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Antiandrogens can treat acne, hirsutism, and seborrhea by reducing sebum production and androgen action.

Squaric acid dibutylester can cause severe skin reactions in people with allergies.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Intralesional steroids effectively treated a young female's scalp nodules without recurrence.

WS PRO 160 I 120 mg effectively treats urinary symptoms from BPH with good safety and tolerability.

A new method to make Finasteride is more cost-effective and yields 16%.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Compounds from Ziziphus spina-christi roots show strong antibacterial and antioxidant potential.

Amino acid supplements may not be necessary for all women with chronic hair loss.

A new amino acid derivative, ATS, improves hair texture and moisture, making it easier to straighten curly hair.

Hair lotions with 17 alpha-estradiol can reduce hair loss but won't regrow new hair.

Polyethylene glycol improves the extraction of beneficial compounds from horsetail.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

The skin's layers protect, sense, and regulate the body's internal balance, but can be prone to cancer.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Androgens can both increase and decrease hair growth in different parts of the body.

Hormone therapy for trans individuals is effective and generally safe in the short term.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.